Heparin-containing block copolymers: Part II: In vitro and ex vivo blood compatibility

I. Vulić, T. Okano, F.J. van der Gaag, S.W. Kim, Jan Feijen

Research output: Contribution to journalArticleAcademicpeer-review

11 Citations (Scopus)
70 Downloads (Pure)

Abstract

Newly synthesized heparin-containing block copolymers, consisting of a hydrophobic block of polystyrene (PS), a hydrophilic spacer-block of poly (ethylene oxide) (PEO) and covalently bonded heparin (Hep) as bioactive block, were coated either onto glass, poly (dimethylsiloxane), polyurethane or PS substrates. Coated surfaces were characterized by determination of the surface-bound heparin activity, adsorption of AT III, plasma recalcification time assays, adhesion of platelets and by an ex vivo rabbit A-A shunt model. It was demonstrated that heparin was available at the surface of all heparin-bound surfaces to interact with AT III and thrombin and to prevent the formation of clots. The maximum immobilized heparin activity was found to be 5.5×10-3 U cm-2. Coated surfaces showed a significant prolongation of the plasma reclacification times as compared to control surfaces, due to surface-immobilized heparin. The platelet adhesion demonstrated that platelets reacted only minimally with the heparin-containing block copolymers in the test system and that the heparin-containing block copolymers seemed to passify the surface as compared to control surfaces. In the ex vivo A-A shunt experiments, which were carried out under low flow and low shear conditions, the heparin-containing block copolymers exhibited prolonged occlusion times, indicating the ability of the heparin-containing block copolymers to reduce thrombus formation at the surface.
Original languageEnglish
Pages (from-to)448-459
Number of pages12
JournalJournal of materials science. Materials in medicine
Volume4
Issue number5
DOIs
Publication statusPublished - 1993

Keywords

  • METIS-105271
  • IR-60756

Fingerprint Dive into the research topics of 'Heparin-containing block copolymers: Part II: In vitro and ex vivo blood compatibility'. Together they form a unique fingerprint.

Cite this